Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec 4;5(1):285.
doi: 10.1038/s41392-020-00425-y.

Characteristics of SARS-CoV-2-specific cytotoxic T cells revealed by single-cell immune profiling of longitudinal COVID-19 blood samples

Affiliations
Comment

Characteristics of SARS-CoV-2-specific cytotoxic T cells revealed by single-cell immune profiling of longitudinal COVID-19 blood samples

Qing Xiong et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
SARS-CoV-2-specific clonal T cells showed signs of long-term survival fate in circulation. a Clustering of 22,452 T cells from five patients (PA0130–34, Supplementary Table S7) at three or two consecutive time points and two healthy donors. All T cells are with both TCR and gene expression information. The cell subsets are color-coded. The labeled markers of each cluster in the UMAP are selected from the top 20 differentially expressed genes (DEGs) of each cluster. b T cell clones indicated by different colors. Clonal T cells were defined as those T cells with identical CDR3 seq/total T cells ≥1%. Non-clonal T cells are defined as those with the rate <1%. The dashed circles indicate the naive-EFF T and effector T cell population, respectively. c Expression of the selected DEGs in each cluster. d T cell clonality in five patients at the indicated time points and two healthy donors; the proportion and CDR3 amino acid sequences of the TRA and TRB of each clone across time points is shown. T cell clones are indicated by different colors. e DEGs between clonal effector (EFF) CD8+ T cells and non-expanded EFF CD8+ T cells (one cell per clone) measured by the Wilcoxon Rank Sum test. DEGs were identified based on fold change >2 and adjusted p-value < 0.01. The analyzed T cells are from an effector T cell population of five patients during virus infection (Timepoint 1). f Expression levels of six co-inhibitory molecules in the clonal CD8+ T cells; LAG3 was the dominant co-inhibitory molecule expressed by 42% of clonal T cells. g The percentages of clonal CD8+ T cells with the indicated co-inhibitory receptor expression in the entire clonal CD8+ T cell population for each patient. *P < 0.05, ** P < 0.01 according to paired t-test. h DEGs across three consecutive time points for the clonal CD8+ T cells of five patients. Wilcoxon Rank Sum test was used for differential expression analysis; DEGs were selected based on fold change >2 and adjusted p-value < 0.01 in two phases. i Flow cytometric analysis of TCR-transfected (TCR sequences from clonal T cells or non-expanded T cells) CD8+ T cells co-cultured for 48 h with Ag-APC (virus antigen loading antigen-presenting cell) or mock APC. j Representative ELISpot wells from patients PA0130 and 0131 showing granzyme B released by TCR-T cells in response to virus antigens. The experiments were technically repeated three times. The difference between groups was analyzed by unpaired t-test

Comment on

References

    1. Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 2020;368:860–868. doi: 10.1126/science.abb5793. - DOI - PMC - PubMed
    1. Jiao S, et al. Differences in tumor microenvironment dictate T helper lineage polarization and response to immune checkpoint therapy. Cell. 2019;179:1177–1190.e13. doi: 10.1016/j.cell.2019.10.029. - DOI - PubMed
    1. Odorizzi PM, Wherry EJ. Inhibitory receptors on lymphocytes: insights from infections. J. Immunol. 2012;188:2957–2965. doi: 10.4049/jimmunol.1100038. - DOI - PMC - PubMed
    1. Long QX, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 2020;26:1200–1204. doi: 10.1038/s41591-020-0965-6. - DOI - PubMed
    1. Grifoni A, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181:1489–1501.e15. doi: 10.1016/j.cell.2020.05.015. - DOI - PMC - PubMed